Rare diseases
Investigational molecules
Locations
Via Ardeatina 306, 00179 Rome, Italy
Clinical research at Fondazione Santa Lucia includes studies in mild to moderate Alzheimer’s disease, with attention to frontal lobe cognitive functions and memory-related decline.
The sponsor is involved in therapeutic work aimed at understanding and addressing cognitive symptoms associated with progressive neurodegenerative conditions.
Fondazione Santa Lucia runs clinical trials in conditions such as Substance use disorder, Dementia Alzheimer's type, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease
CzechiaOxytocin Nasal Spray for Reducing Cravings and Preventing Relapse in Adults with Substance Use Disorder
ItalyA study to evaluate the effects of rifaximin in patients with opioid use disorder
ItalyStudy on Oxytocin and Sodium Chloride for Preventing Drug Relapse in Individuals with Substance Use Disorder
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
